Fortress Biotech, Inc.
Symbol: FBIO (NASDAQ)
4.00
▲ (6.67%) 0.250
Company Description:
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
Key Stats
- Today's Open: $3.79
- Today's High: $4
- Today's Low: $3.595
- Today's Volume: 1.22M
- Yesterday Close: $3.75
- Yesterday High: $3.88
- Yesterday Low: $3.59
- Yesterday Volume: 1.21M
- Last Min Volume: 18
- Last Min High: $4
- Last Min Low: $3.975
- Last Min VWAP: $3.995
Company Profile
- Name: Fortress Biotech, Inc.
- Website: https://www.fortressbiotech.com
- Listed Date: 2011-11-17
- Location: BAY HARBOR ISLANDS, FL
- Market Status: Active
- CIK Number: 0001429260
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $116.34M
- Round Lot: 100
- Outstanding Shares: 29.75M
- Asset Type: CS
RECENT FILINGS FOR FBIO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-08-01 | 424B7 | View |
| 2025-07-16 | 8-K | View |
| 2025-06-23 | 8-K | View |
| 2025-06-05 | 8-K | View |
| 2025-06-03 | SCHEDULE 13D/A | View |
| 2025-06-03 | 4 | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-15 | 8-K | View |
| 2025-04-28 | DEFA14A | View |
| 2025-04-28 | DEF 14A | View |
| 2025-04-18 | PRE 14A | View |
| 2025-04-16 | 8-K | View |
| 2025-04-02 | EFFECT | View |
| 2025-04-02 | EFFECT | View |
| 2025-04-02 | EFFECT | View |
| 2025-04-02 | EFFECT | View |
| 2025-04-02 | SCHEDULE 13D/A | View |
| 2025-04-02 | SCHEDULE 13D/A | View |
Latest News on FBIO